High prevalence of hepatitis B virus infection in multiple myeloma

Leukemia and Lymphoma

Volumn 53, Issue 2, 2012, Pages 270-274

  Huang, Beihui ^a   Li, Juan ^a   Zhou, Zhenhai ^a   Zheng, Dong ^a   Liu, Junru ^a   Chen, Mei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatic injury; Hepatitis B virus; Hepatitis C virus; Multiple myeloma; Overall survival

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; MELPHALAN; PIRARUBICIN; THALIDOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84862908382     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.610013     Document Type: Article

References (19)

1. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2009;122:98-102.
2. Wang YM, Tang YZ. Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 2009;8:17-24.
3. Sun Z, Ming L, Zhu X, et al. Prevention and control of hepatitis B in China. J Med Virol 2002;67:447-450.
4. Noonan CA, Yoffe B, Mansell PW, et al. Extrachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquireDimmune defi ciency syndrome patients. Proc Natl Acad Sci USA 1986;83:5698-5702. (Pubitemid 16001284)
5. Lerat H, Rumin S, Habersetzer F, et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: infl uence of viral load, viral genotype, and cell phenotype. Blood 1998;91:3841-3849. (Pubitemid 28225753)
6. Wang F, Xu RH, Han B, et al. High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 2007;109:1360-1364. (Pubitemid 46466563)
7. Park SC, Jeong SH, Kim J, et al. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin ' s lymphoma in Korea. J Med Virol 2008;80:960-966. (Pubitemid 351657005)
8. Chen MH, Hsiao LT, Chiou TJ, et al. High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin ' s lymphoma. Ann Hematol 2008;87:475-480.
9. Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B-cell non-Hodgkin ' s lymphoma. Haematologica 2006;91:554-557.
10. Montella M, Crispo A, Russo F, et al. Hepatitis C virus infection and new association wiThextrahepatic disease: multiple myeloma. Haematologica 2000;85:883-884.
11. Gharagozloo S, Khoshnoodi J, Shokri F. Hepatitis C virus infection in patients wiThessential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia. Pathol Oncol Res 2001;7: 135-139. (Pubitemid 32729765)
12. umin S, Habersetzer F, et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: infl uence of viral load, viral genotype, and cell phenotype. Blood 1998;91:3841-3849. (Pubitemid 28225753)
13. Yoffe B, Noonan CA, Melnick JL, et al. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis 1986;153: 471-477. (Pubitemid 16135650)
14. Izumi T, Sasaki R, Tsunoda S, et al. B cell malignancy and hepatitis C virus infection. Leukemia 1997;11(Suppl. 3):516-518.
15. Takai S, Tsurumi H, Ando K, et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005;74:158-165. (Pubitemid 40175321)
16. Kuniyoshi M, Nakamuta M, Sakai H, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin ' s lymphoma. J Gastroenterol Hepatol 2001;16:215-219. (Pubitemid 32226196)
17. Takeshita M, Sakai H, Okamura S, et al. Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan. Histopathology 2006;48:189-198.
18. Lim ST, Fei G, Quek R, et al. The relationship of hepatitis B virus infection and non-Hodgkin ' s lymphoma anDits impact on clinical characteristics and prognosis. Eur J Haematol 2007;79:132-137. (Pubitemid 47063256)
19. Engels EA, Cho ER, Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol 2010;11:827-834.